Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Dutch lactic acid and derivatives maker Purac intends to build a $20 million plant to make resorbable lactide-based polymers for the biomedical market in the U.S. The company aims to begin construction of the plant next year. Separately, Purac and Arkema have announced a collaboration in lactide-based block copolymers. The effort will combine Arkema’s expertise in ring-opening polymerization catalysis with Purac’s L- and D-lactide monomers.
This article has been sent to the following recipient: